Linde Ag Spon (NASDAQ:LNEGY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday, June 17th.

According to Zacks, “The Linde Group is an engineering company which supplies industrial, process and specialty gases worldwide. The Company’s core operating segments consist of the gases and engineering division. The main gases produced by the Company are acetylene, carbon dioxide, nitrogen, hydrogen, shielding gases for welding applications, noble gases, calibration gas mixtures, high-purity gases and gas mixtures. It also supplies welding and safety products. Lindes’s pharmaceutical and medical gas products and services find their use in clinical care, emergency care, and ventilation therapy and hospital infrastructure. The engineering division focuses on plant engineering for the production of hydrogen and synthesis gas, oxygen and olefins as well as plants for natural gas treatment. The Company’s non core division the gist division operates in a wide range of commercial and industrial sectors including grocery, retail, electronics and gas. . The Linde Group is headquartered in Munich, Germany. “

Separately, HSBC Holdings plc raised shares of Linde Ag Spon from a “hold” rating to a “buy” rating in a report on Thursday, May 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $22.00.

Linde Ag Spon (LNEGY) traded up 0.45% on Friday, hitting $19.96. The stock had a trading volume of 22,314 shares. Linde Ag Spon has a 1-year low of $13.93 and a 1-year high of $20.16. The company’s 50 day moving average is $19.26 and its 200-day moving average is $17.33. The firm has a market capitalization of $37.07 billion and a price-to-earnings ratio of 27.90.

TRADEMARK VIOLATION NOTICE: “Linde Ag Spon (NASDAQ:LNEGY) Cut to “Hold” at Zacks Investment Research” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at

Get a free copy of the Zacks research report on Linde Ag Spon (LNEGY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Stock Ratings for Linde Ag Spon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde Ag Spon and related stocks with our FREE daily email newsletter.